Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.
about
Elevated risk of venous thromboembolic events in patients with inflammatory myopathiesPrimary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the LiteratureHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationRisk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Risk of venous thromboembolism in patients with celiac disease: A systematic review and meta-analysis.Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia.Long-term complications of splenectomy in adult immune thrombocytopenia.Venous thrombosis and prothrombotic factors in inflammatory bowel disease.Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.Risk of venous thromboembolism in patients with rheumatoid arthritis.Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases.Acute cardiac disorder or pneumonia and concomitant presence of pulmonary embolism.Selection bias in rheumatic disease research.Thrombosis in vasculitis: from pathogenesis to treatment.Aspirin and multiple sclerosisRisk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis.Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with organophosphate intoxication: a nationwide prospective cohort studyNeutrophil extracellular trap (NET) impact on deep vein thrombosis.Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjogren's syndrome.Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary CholangitisPulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases.Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta-analysisInherited and secondary thrombophilia.Risk of vascular disease in patients with multiple sclerosis: a review.Autoimmune diseases and venous thromboembolism: a review of the literature.Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis.The complement system in systemic lupus erythematosus: an update.Postoperative risk of venous thromboembolism in rheumatic disease patients.
P2860
Q26746904-5B5D0755-48DB-498E-9812-B1450DAB7E2AQ27023818-C3BDCEB6-5B48-4CD6-885A-C90E2688BD9BQ29547691-FDBF9B6B-6F3C-4BB9-A79A-B95761AD0322Q30205757-F5857065-27AF-4F5A-B456-AE6C10801524Q30250259-70841DA4-25BA-472B-ADE5-8CB6EBE984BAQ30251989-22A70C3A-F0D8-4079-9130-7E41DE788E7EQ33407110-59F8C218-B654-410B-B811-FFBB1F412E22Q33409611-0295FDEB-E720-4A5F-9085-43BA15A709F8Q33415996-A9AF5926-E239-44B4-B999-298E31EE199BQ33424664-8F578AEB-0D19-4D1B-A6B4-27F2EAA3EFC4Q33425644-63D86709-3414-4ADC-A529-06498C2CC9CBQ33431551-3E4D9B93-4C1C-45FA-A427-E455142237BEQ33434927-07301B33-F491-4465-BD6A-524487E1B288Q33437227-21D74A80-AC09-4349-A681-C1C78505B7F7Q33564092-0DC1B0EC-5AF8-46F7-ADED-32916BB42F93Q33588440-1984AC54-79D1-455F-A34E-00C4E2E45E84Q33822203-C6A1082B-CDFB-4630-9A6C-8C75E2AC6043Q33877737-8DE52DD7-EFDC-4E5E-8FD1-33F7D02CB71FQ33926524-CF1B9308-2012-43F7-AA69-61AFFF5A8F50Q34284224-4FF022E1-E6B9-4B55-82F0-B0C272E8776CQ34392922-5987B335-2154-4D4D-A413-5155BACF21C7Q34455241-93FFCEAB-6906-4280-AD9D-1C84B622F4CFQ34662693-1007C937-0BC1-4983-BC06-9DB7CC7B1698Q35440601-E461ABCF-2040-4520-B8BD-B2BB0F27FE57Q35678040-0DA264E0-2E75-40AC-9AF4-10F2E12266A8Q35770811-3DDFF062-4910-4212-AB7E-BC819B85BD5CQ36024830-44F00324-FA77-460D-8FAB-5F63AA1586BCQ36152749-6FFAB624-2CC2-4692-A2B2-B2D29D175683Q36391500-606F4676-9448-4081-89D4-F921B9B90BCBQ36889466-CDAE886C-7D4E-482C-8B88-22553908BCDCQ36914749-A0655206-874C-46E5-8A65-E38CDD8C9290Q37334817-68349287-7D2F-4805-BB1D-4FC467DDCF36Q37419638-3E39DFC4-9FD6-491D-8F8C-AF072BC06A91Q37691562-54F88971-042F-4027-AA85-048E99785AA5Q38019658-4AA1149C-5A32-4655-A0C9-D9B5CBDBAF17Q38039441-8D263216-C625-46B5-A5C3-E2C471048ED1Q38059460-CD2C35A4-90D3-4BDD-AB97-84AB2B65396DQ38205734-035F117D-476E-47EF-9748-79011D52FED3Q38213193-4BA73B3E-F07C-40B8-8906-47FCABBD2043Q38359475-E9550ADB-8174-40C1-B2D2-3BD4B4FE4B38
P2860
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@ast
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@en
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@nl
type
label
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@ast
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@en
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@nl
prefLabel
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@ast
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@en
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@nl
P50
P1433
P1476
Risk of pulmonary embolism in ...... e follow-up study from Sweden.
@en
P304
P356
10.1016/S0140-6736(11)61306-8
P407
P577
2011-11-25T00:00:00Z